Novo Nordisk A/S
Insulin containing pharmaceutical compositions
Last updated:
Abstract:
The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.
Status:
Grant
Type:
Utility
Filling date:
20 Feb 2019
Issue date:
24 Mar 2020